采衡

Shanghai Caiheng Biotechnology (Caiheng Bio) is a biotechnology company that specializes in the development and production of recombinant proteins and antibodies. Operating alongside its sister company, Caiheng Medical Technology, the firm provides a wide range of products and services, including custom protein expression, antibody development, and diagnostic reagents for the life sciences research and IVD sectors. Additionally, the group is involved in the R&D of high-end vascular interventional medical devices, such as catheters and guide wires for cardiovascular and neurovascular applications. Backed by investors like Sherpa Healthcare Partners, Caiheng Bio leverages its technical expertise to support drug discovery and clinical intervention.